| When: Monday, 11/1/2021, 5:00 pm - 6:30 pm |
| Credits: 1.5 CME_Physicians Credits |
| Credits: 1.5 CME_OtherProfessions Credits |
|
Description: Searching for the latest recommendations and position statements about the prevention and treatment of childhood and adolescent obesity? Get a (virtual) front row seat for the first joint American Academy of Pediatrics/The Obesity Society (AAP/TOS) symposium. The American Academy of Pediatrics is committed to the optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults. Come hear about their position statements on Stigma Experienced by Children and Adolescents With Obesity, Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents, Physical Activity Assessment and Counseling in Pediatric Clinical Settings, and Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices. This symposium focuses on the current AAP Position Statements, with a unique view of the authors themselves! Share your thoughts and questions in the Q&A discussion and build excitement for the much anticipated AAP Pediatric Obesity Guidelines to be published in the Spring of 2022.
|
| Delivery Mechanism: Broadcast |
| Keyword: Policy: Stigma/Weight Bias; Treatment: Surgery/Devices |
Track: Sub-track: Pediatrics; Track 5: Clinical/Professional Practice; Track 6: Policy/Public Health
|
|
Speakers:
 | Ania M. Jastreboff, MD, PhD | Session Co-Chair | |  | Aaron S. Kelly, PhD | Session Co-Chair | |  | Sarah C. Armstrong, MD | AAP Statement on Stigma Experienced by Children and Adolescents With Obesity | 5:00 pm - 5:15 pm |  | John C. Rausch, MD | AAP Statement on Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents | 5:15 pm - 5:30 pm |  | Natalie D. Muth, MD, MPH, RDN | AAP Statement on Physical Activity Assessment and Counseling in Pediatric Clinical Settings | 5:30 pm - 5:45 pm |  | Marc P. Michalsky, MD, MBA | AAP Statement on Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices | 5:45 pm - 6:00 pm | | Ania M. Jastreboff, MD, PhD | Moderate Q&A | 6:00 pm - 6:30 pm | | Aaron S. Kelly, PhD | Moderate Q&A | 6:00 pm - 6:30 pm | | Sarah C. Armstrong, MD | Panel Q&A | 6:00 pm - 6:30 pm | | John C. Rausch, MD | Panel Q&A | 6:00 pm - 6:30 pm | | Natalie D. Muth, MD, MPH, RDN | Panel Q&A | 6:00 pm - 6:30 pm | | Marc P. Michalsky, MD, MBA | Panel Q&A | 6:00 pm - 6:30 pm |
|
|
| Learning Objectives: |
| 1. Apply the latest recommendations for evaluation and treatment; tailor intervention strategies based on patient characteristics such as age or metabolic or behavioral phenotype; understand the differences between weight loss and weight loss maintenance. |
| 3. Implement appropriate testing strategies for diagnosing adolescent and pediatric obesity, evaluate current treatment options and emerging therapeutics and provide care and treatment to adolescent and pediatric patients accordingly. Teach evidence-based strategies for obesity prevention in the pediatric and adolescent population. |
| 5. Apply new knowledge related to dietary intervention and physical activity from the perspectives of Metabolism and Integrative Physiology, Neuroscience, Intervention and Clinical Studies, Population Health, Clinical/Professional Practice, and Policy/Public Health. |
|
|